Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

Sponsor

McMaster University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05325138

Collaborator

Merck Canada Inc. (Industry)

Enrollment

Location

10.6

Anticipated Duration (Months)

4.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. To do this, we will conduct in-depth qualitative interviews with purposively sampled parents of girls aged 9 to 14 years, some of whom received HPV vaccine and some of whom did not. Interviews will continue until thematic saturation is reached (We anticipate a total 40 interviews). Data analysis will be done concurrently with interviews using thematic analysis.

Condition or Disease	Intervention/Treatment	Phase
Vaccine Refusal	Other: Interview

Detailed Description

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. Snowball sampling technique will be used. Parents of girls aged 9-14years will be included if the daughters have or have not received the HPV vaccine. Exclusion criteria include parents who are health care workers in any health institution, unwilling to provide consent, or inability to converse in English or pidgeon English. In-depth one-on-one interviews will take place using an interview guide. Interviews will be in English or pidgeon English. They will be taped and transcribed. Data will be entered into ATLAS Ti. Data analysis will be done concurrently with interviews using thematic analysis.Interviews will continue until theme saturation is reached (We anticipate a total 40 interviews).

Study Design

Study Type:

Observational

Anticipated Enrollment :

45 participants

Observational Model:

Other

Time Perspective:

Other

Official Title:

Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents With Children Aged 9-14yrs Within Rural Communities in North West Region, Cameroon

Actual Study Start Date :

Mar 14, 2022

Anticipated Primary Completion Date :

Jan 31, 2023

Anticipated Study Completion Date :

Jan 31, 2023

Arms and Interventions

Arm	Intervention/Treatment
Parents Parents of girls aged 9-14 years old	Other: Interview Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination

Arm

Intervention/Treatment

Parents

Parents of girls aged 9-14 years old

Other: Interview

Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination

Outcome Measures

Primary Outcome Measures

HPV vaccine knowledge, attitudes and beliefs [6months]
Interviews of parents of girls (ages 9-14 years old)

Eligibility Criteria

Criteria

Ages Eligible for Study:

21 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Parents of girls aged 9-14 years old living in Mbingo, Njinikom or Fundong health areas of northwestern Cameroon.

Exclusion Criteria:

Parents who are health care workers or working in any health institution.
Not willing to provide informed consent
Not able to converse in English or pidgeon English

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Mbingo Hosptial	Bamenda	North West	Cameroon

Sponsors and Collaborators

McMaster University
Merck Canada Inc.

Investigators

Principal Investigator: Lorraine M Elit, MD MSc, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Lorraine Elit, MD, Professor Emeritus, McMaster University

ClinicalTrials.gov Identifier:

NCT05325138

Other Study ID Numbers:

100035

First Posted:

Apr 13, 2022

Last Update Posted:

Apr 13, 2022

Last Verified:

Apr 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Lorraine Elit, MD, Professor Emeritus, McMaster University

HPV vaccine, parental perspective, qualitative study

Study Results

No Results Posted as of Apr 13, 2022